Compare FIVE & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIVE | BIO |
|---|---|---|
| Founded | 2002 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 10.1B |
| IPO Year | 2012 | 1994 |
| Metric | FIVE | BIO |
|---|---|---|
| Price | $218.62 | $361.51 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 26 | 3 |
| Target Price | $305.27 | ★ $328.33 |
| AVG Volume (30 Days) | ★ 980.0K | 244.1K |
| Earning Date | 12-02-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 40.65 | ★ 142.61 |
| EPS | ★ 6.20 | N/A |
| Revenue | ★ $4,764,147,000.00 | $2,583,200,000.00 |
| Revenue This Year | $19.86 | N/A |
| Revenue Next Year | $9.26 | $2.13 |
| P/E Ratio | $34.41 | ★ N/A |
| Revenue Growth | ★ 22.90 | 0.65 |
| 52 Week Low | $143.02 | $236.73 |
| 52 Week High | $263.88 | $396.23 |
| Indicator | FIVE | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 45.45 | 44.01 |
| Support Level | $215.63 | $358.85 |
| Resistance Level | $235.56 | $391.87 |
| Average True Range (ATR) | 7.88 | 12.48 |
| MACD | -0.13 | -1.98 |
| Stochastic Oscillator | 58.27 | 23.13 |
Five Below Inc is a specialty value retailer offering a broad range of trend-right, high-quality products loved by the kid and the kid in all of customers. The Company's edited assortment of products includes select brands and licensed merchandise. The Company also sells its merchandise on the internet, through the Company's e-commerce website and mobile app, offering home delivery and the option to buy online and pick up in store. Additionally, the Company sells merchandise through on-demand third-party delivery services to enable its customers to shop online and receive convenient delivery. It derives revenue from sales of the Company's merchandise to customers.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.